NO992725D0 - 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer - Google Patents

6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer

Info

Publication number: NO992725D0
Authority: NO; Norway
Prior art keywords: phenylpyridyl; amine derivatives; derivatives useful; nos inhibitors; inhibitors
Prior art date: 1996-12-06

Application number

NO992725A

Other languages

English (en)

Other versions

NO313517B1 (no

NO992725L (no

Inventor

Iii John Adams Lowe

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-06

Filing date

1999-06-04

Publication date

1999-06-04

1999-06-04 Application filed by Pfizer filed Critical Pfizer

1999-06-04 Publication of NO992725D0 publication Critical patent/NO992725D0/no

1999-06-04 Publication of NO992725L publication Critical patent/NO992725L/no

2002-10-14 Publication of NO313517B1 publication Critical patent/NO313517B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

NO19992725A 1996-12-06 1999-06-04 6-Fenylpyridyl-2-aminderivater, anvendelse av disse og farmasöytiske preparater inneholdende dem NO313517B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3279396P	1996-12-06	1996-12-06
PCT/IB1997/001446 WO1998024766A1 (en)	1996-12-06	1997-11-17	6-phenylpyridyl-2-amine derivatives useful as nos inhibitors

Publications (3)

Publication Number	Publication Date
NO992725D0 true NO992725D0 (no)	1999-06-04
NO992725L NO992725L (no)	1999-06-04
NO313517B1 NO313517B1 (no)	2002-10-14

Family

ID=21866837

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19992725A NO313517B1 (no)	1996-12-06	1999-06-04	6-Fenylpyridyl-2-aminderivater, anvendelse av disse og farmasöytiske preparater inneholdende dem

Country Status (42)

Country	Link
US (3)	US6235750B1 (no)
EP (1)	EP0946512B1 (no)
JP (2)	JP3604399B2 (no)
KR (1)	KR100360633B1 (no)
CN (1)	CN1117077C (no)
AP (1)	AP848A (no)
AR (1)	AR010331A1 (no)
AT (1)	ATE251612T1 (no)
AU (2)	AU4791797A (no)
BG (1)	BG103540A (no)
BR (1)	BR9714381A (no)
CA (1)	CA2273479C (no)
CZ (1)	CZ293863B6 (no)
DE (1)	DE69725465T2 (no)
DK (1)	DK0946512T3 (no)
DZ (1)	DZ2361A1 (no)
EA (1)	EA002907B1 (no)
ES (1)	ES2206691T3 (no)
HN (2)	HN1997000027A (no)
HR (1)	HRP970664A2 (no)
HU (1)	HUP0001848A3 (no)
ID (1)	ID19056A (no)
IL (1)	IL130111A0 (no)
IS (1)	IS5053A (no)
MA (1)	MA26453A1 (no)
NO (1)	NO313517B1 (no)
NZ (1)	NZ335733A (no)
OA (1)	OA11123A (no)
PA (1)	PA8442201A1 (no)
PE (1)	PE46499A1 (no)
PL (1)	PL333918A1 (no)
PT (1)	PT946512E (no)
SI (1)	SI0946512T1 (no)
SK (1)	SK70899A3 (no)
TN (1)	TNSN97198A1 (no)
TR (1)	TR199901259T2 (no)
TW (1)	TW491840B (no)
UA (1)	UA59379C2 (no)
UY (1)	UY24799A1 (no)
WO (1)	WO1998024766A1 (no)
YU (1)	YU25399A (no)
ZA (1)	ZA9710906B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT891332E (pt) *	1996-03-29	2004-07-30	Pfizer	Derivados de 6-fenilpiridil-2-amina
US20010049379A1 (en)	1997-08-27	2001-12-06	Lowe John Adams	2-aminopyridines containing fused ring substituents
HN1998000118A (es) *	1997-08-27	1999-02-09	Pfizer Prod Inc	2 - aminopiridinas que contienen sustituyentes de anillos condensados.
HN1998000125A (es)	1997-08-28	1999-02-09	Pfizer Prod Inc	2-aminopiridinas con sustituyentes alcoxi ramificados
AR019190A1 (es) *	1998-07-08	2001-12-26	Sod Conseils Rech Applic	Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
FR2791674A1 (fr) *	1999-04-02	2000-10-06	Sod Conseils Rech Applic	Nouveaux derives de 2-aminopyridines, leur utilisation en tant que medicaments et compositions pharmaceutiques les contenant
FR2780971B1 (fr) *	1998-07-08	2001-09-28	Sod Conseils Rech Applic	Nouveaux derives de 2-aminopyridines, leur application en tant que medicaments et compositions pharmaceutiques les contenant
EE200100084A (xx) *	1998-08-11	2002-08-15	Pfizer Products Inc.	NOS inhibiitorite uued farmatseutilised kasutusv�imalused
US7115557B2 (en)	1998-09-25	2006-10-03	Sciaticon Ab	Use of certain drugs for treating nerve root injury
SE9803710L (sv)	1998-09-25	2000-03-26	A & Science Invest Ab	Användning av vissa substanser för behandling av nervrotsskador
KR20010114213A (ko)	1999-02-25	2001-12-31	실버스타인 아써 에이.	접합 고리 치환기를 함유한 2-아미노피리딘
AU763976B2 (en) *	1999-07-23	2003-08-07	Shionogi & Co., Ltd.	Th2 differentiation inhibitors
FR2804429B1 (fr) *	2000-01-31	2003-05-09	Adir	Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2002080853A2 (en) *	2001-04-09	2002-10-17	Bristol-Myers Squibb Company	Fused heterocyclic inhibitors of factor xa
US20030045449A1 (en) *	2001-08-15	2003-03-06	Pfizer, Inc.	Pharmaceutical combinations for the treatment of neurodegenerative diseases
BRPI0409307A (pt) *	2003-04-14	2006-04-25	Pfizer Prod Inc	derivados de 3-azabiciclo[3.2.1]octano
CN1295216C (zh) *	2003-07-04	2007-01-17	中国人民解放军军事医学科学院毒物药物研究所	吲哚酮类衍生物及其用于制备抗肿瘤药物的用途
CA2598484A1 (en) *	2005-02-21	2006-08-24	Proximagen Ltd.	Inhibition or treatment of dyskinesia
WO2006105795A1 (en) *	2005-04-08	2006-10-12	Leo Pharma A/S	Novel indolinone derivatives
CN103980151A (zh)	2006-08-09	2014-08-13	史密丝克莱恩比彻姆公司	作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物
JO2972B1 (en)	2007-06-08	2016-03-15	جانسين فارماسوتيكا ان. في	Piperidine / piperazine derivatives
WO2008148851A1 (en)	2007-06-08	2008-12-11	Janssen Pharmaceutica N.V.	Piperidine/piperazine derivatives
CA2687754C (en)	2007-06-08	2015-12-08	Janssen Pharmaceutica N.V.	Piperidine, piperazine derivatives for use as dgat inhibitors
AU2008258549B2 (en)	2007-06-08	2013-11-14	Janssen Pharmaceutica N.V.	Piperidine/piperazine derivatives
WO2009147170A2 (en)	2008-06-05	2009-12-10	Janssen Pharmaceutica Nv	Drug combinations comprising a dgat inhibitor and a ppar-agonist
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
JP5642661B2 (ja) *	2009-03-05	2014-12-17	塩野義製薬株式会社	Ｎｐｙｙ５受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
US11013844B2 (en) *	2014-11-20	2021-05-25	City Of Hope	Treatment device for plasma virus inactivation
DK3497099T3 (da)	2016-08-12	2022-05-23	Athenex Inc	Biarylsammensætninger og fremgangsmåder til modulering af en kinasekaskade
NZ762985A (en)	2017-09-22	2024-03-22	Jubilant Epipad LLC	Heterocyclic compounds as pad inhibitors
HUE061607T2 (hu)	2017-10-18	2023-07-28	Jubilant Epipad LLC	Imidazopiridin vegyületek mint PAD inhibitorok
CN111386265A (zh)	2017-11-06	2020-07-07	朱比连特普罗德尔有限责任公司	作为pd1/pd-l1活化的抑制剂的嘧啶衍生物
EP3704120B1 (en)	2017-11-24	2024-03-06	Jubilant Episcribe LLC	Heterocyclic compounds as prmt5 inhibitors
BR112020018610A2 (pt)	2018-03-13	2020-12-29	Jubilant Prodel LLC	Compostos de fórmula i, fórmula ii, fórmula iii, fórmula iv, fórmula v, fórmula vi, ou seus polimorfos, estereoisômeros, tautômeros, profármacos, solvatos e sais farmaceuticamente aceitáveis dos mesmos e uso dos mesmos; processo de preparação; composição farmacêutica; e método para o tratamento e/ou prevenção de várias doenças, que incluem câncer e doenças infecciosas
JP2022537140A (ja) *	2019-06-14	2022-08-24	エスアールエックスカーディオ，エルエルシー	プロタンパク質転換酵素サブチリシン／ケキシン９型（ｐｃｓｋ９）の調節のための化合物
US20220193058A1 (en) *	2020-12-16	2022-06-23	Srx Cardio, Llc	Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992014780A1 (en)	1991-02-19	1992-09-03	Akzo N.V.	Stabilized carbon monoxide-olefin copolymers
WO1994014780A1 (en) *	1992-12-18	1994-07-07	The Wellcome Foundation Limited	Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
US5621004A (en)	1994-06-03	1997-04-15	Robert W. Dunn	Method for treating emesis
WO1996018616A1 (en) *	1994-12-12	1996-06-20	Merck & Co., Inc.	Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
PT891332E (pt) *	1996-03-29	2004-07-30	Pfizer	Derivados de 6-fenilpiridil-2-amina
US6093743A (en)	1998-06-23	2000-07-25	Medinox Inc.	Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor

1997
- 1997-02-18 HN HN1997000027A patent/HN1997000027A/es unknown
- 1997-11-17 CZ CZ19992017A patent/CZ293863B6/cs not_active IP Right Cessation
- 1997-11-17 SK SK708-99A patent/SK70899A3/sk unknown
- 1997-11-17 JP JP52539798A patent/JP3604399B2/ja not_active Expired - Fee Related
- 1997-11-17 NZ NZ335733A patent/NZ335733A/xx unknown
- 1997-11-17 UA UA99063103A patent/UA59379C2/uk unknown
- 1997-11-17 YU YU25399A patent/YU25399A/sh unknown
- 1997-11-17 BR BR9714381-2A patent/BR9714381A/pt not_active Application Discontinuation
- 1997-11-17 HU HU0001848A patent/HUP0001848A3/hu unknown
- 1997-11-17 IL IL13011197A patent/IL130111A0/xx unknown
- 1997-11-17 CN CN97180350A patent/CN1117077C/zh not_active Expired - Fee Related
- 1997-11-17 PL PL97333918A patent/PL333918A1/xx unknown
- 1997-11-17 DE DE69725465T patent/DE69725465T2/de not_active Expired - Fee Related
- 1997-11-17 ES ES97910587T patent/ES2206691T3/es not_active Expired - Lifetime
- 1997-11-17 PT PT97910587T patent/PT946512E/pt unknown
- 1997-11-17 AU AU47917/97A patent/AU4791797A/en not_active Abandoned
- 1997-11-17 SI SI9730597T patent/SI0946512T1/xx unknown
- 1997-11-17 EA EA199900448A patent/EA002907B1/ru not_active IP Right Cessation
- 1997-11-17 EP EP97910587A patent/EP0946512B1/en not_active Expired - Lifetime
- 1997-11-17 TR TR1999/01259T patent/TR199901259T2/xx unknown
- 1997-11-17 WO PCT/IB1997/001446 patent/WO1998024766A1/en active IP Right Grant
- 1997-11-17 KR KR1019997004981A patent/KR100360633B1/ko not_active IP Right Cessation
- 1997-11-17 AT AT97910587T patent/ATE251612T1/de not_active IP Right Cessation
- 1997-11-17 CA CA002273479A patent/CA2273479C/en not_active Expired - Fee Related
- 1997-11-17 DK DK97910587T patent/DK0946512T3/da active
- 1997-11-18 HN HN1997000149A patent/HN1997000149A/es unknown
- 1997-11-22 TW TW086117501A patent/TW491840B/zh active
- 1997-12-01 PE PE1997001080A patent/PE46499A1/es not_active Application Discontinuation
- 1997-12-03 MA MA24884A patent/MA26453A1/fr unknown
- 1997-12-03 DZ DZ970211A patent/DZ2361A1/xx active
- 1997-12-03 TN TNTNSN97198A patent/TNSN97198A1/fr unknown
- 1997-12-03 UY UY24799A patent/UY24799A1/es unknown
- 1997-12-04 AR ARP970105713A patent/AR010331A1/es not_active Application Discontinuation
- 1997-12-04 HR HR60/032,793A patent/HRP970664A2/hr not_active Application Discontinuation
- 1997-12-04 AP APAP/P/1997/001156A patent/AP848A/en active
- 1997-12-04 PA PA19978442201A patent/PA8442201A1/es unknown
- 1997-12-04 ZA ZA9710906A patent/ZA9710906B/xx unknown
- 1997-12-05 ID IDP973838A patent/ID19056A/id unknown
1999
- 1999-05-18 IS IS5053A patent/IS5053A/is unknown
- 1999-06-01 OA OA9900115A patent/OA11123A/en unknown
- 1999-06-03 US US09/325,480 patent/US6235750B1/en not_active Expired - Fee Related
- 1999-06-04 NO NO19992725A patent/NO313517B1/no unknown
- 1999-06-30 BG BG103540A patent/BG103540A/bg unknown
2001
- 2001-03-08 US US09/802,086 patent/US20020032191A1/en not_active Abandoned
- 2001-09-13 AU AU72050/01A patent/AU766080B2/en not_active Ceased
- 2001-09-27 US US09/965,564 patent/US20020103227A1/en not_active Abandoned
2004
- 2004-06-24 JP JP2004186311A patent/JP2005170924A/ja active Pending

Also Published As

Publication number	Publication date
HRP970664A2 (en)	1998-10-31
CN1117077C (zh)	2003-08-06
EA199900448A1 (ru)	2000-02-28
NO313517B1 (no)	2002-10-14
DZ2361A1 (fr)	2002-12-28
EP0946512A1 (en)	1999-10-06
ID19056A (id)	1998-06-11
BR9714381A (pt)	2000-05-02
BG103540A (bg)	2000-12-29
EP0946512B1 (en)	2003-10-08
ATE251612T1 (de)	2003-10-15
DE69725465D1 (de)	2003-11-13
HUP0001848A2 (hu)	2001-04-28
NZ335733A (en)	2001-01-26
TNSN97198A1 (fr)	2005-03-15
NO992725L (no)	1999-06-04
HN1997000027A (es)	1997-06-05
AR010331A1 (es)	2000-06-07
AP9701156A0 (en)	1998-01-31
CA2273479C (en)	2006-02-07
US6235750B1 (en)	2001-05-22
TW491840B (en)	2002-06-21
DK0946512T3 (da)	2004-01-12
DE69725465T2 (de)	2004-05-06
PT946512E (pt)	2004-01-30
PE46499A1 (es)	1999-05-12
PA8442201A1 (es)	2000-05-24
IL130111A0 (en)	2000-06-01
CZ293863B6 (cs)	2004-08-18
JP2005170924A (ja)	2005-06-30
HUP0001848A3 (en)	2002-03-28
UY24799A1 (es)	2001-08-27
CZ201799A3 (cs)	2000-07-12
CN1239952A (zh)	1999-12-29
KR20000057413A (ko)	2000-09-15
AU4791797A (en)	1998-06-29
OA11123A (en)	2003-04-07
US20020103227A1 (en)	2002-08-01
WO1998024766A1 (en)	1998-06-11
SI0946512T1 (en)	2004-04-30
HN1997000149A (es)	1997-12-26
YU25399A (sh)	2001-07-10
IS5053A (is)	1999-05-18
AU7205001A (en)	2001-11-15
MA26453A1 (fr)	2004-12-20
AP848A (en)	2000-06-09
JP2000505814A (ja)	2000-05-16
ZA9710906B (en)	1999-06-09
KR100360633B1 (ko)	2002-11-13
SK70899A3 (en)	2002-04-04
EA002907B1 (ru)	2002-10-31
PL333918A1 (en)	2000-01-31
TR199901259T2 (xx)	1999-08-23
US20020032191A1 (en)	2002-03-14
AU766080B2 (en)	2003-10-09
CA2273479A1 (en)	1998-06-11
UA59379C2 (uk)	2003-09-15
ES2206691T3 (es)	2004-05-16
JP3604399B2 (ja)	2004-12-22

Publication	Publication Date	Title
NO992725L (no)	1999-06-04	6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO986090D0 (no)	1998-12-23	Fenylalaninderivater som integrininhibitorer
DK2253620T3 (da)	2014-03-31	Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DK0818448T3 (da)	2004-03-22	Cycloalkanopyridiner som CETP-inhibitorer
NO992821D0 (no)	1999-06-10	Ketobenzamider som calpain-inhibitorer
DK1244647T3 (da)	2006-09-25	Quinzolinderivater som VIGF-inhibitorer
NO980467D0 (no)	1998-02-03	4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
ATE323682T1 (de)	2006-05-15	Aryl-pyrimidin-derivate
DK0891332T3 (da)	2004-07-05	6-phenylpyridyl-2-aminderivater
IS4800A (is)	1998-07-21	Nýjar 19-nor-pregnene afleiður
DK1027332T3 (da)	2004-10-04	Hidtil ukendte lactametalloproteaseinhibitorer
NO981946D0 (no)	1998-04-29	Imidazoquinazolin-derivater
DK0958287T3 (da)	2003-01-20	Sulfamidmetalloprotease-inhibitorer
DK1097127T3 (da)	2003-06-10	Diacylhydrazinderivater som integrininhibitorer
PT956294E (pt)	2004-10-29	Inibidores da trombina
DE69732576D1 (de)	2005-03-31	Tetrahydrobenzindolon-derivate
NO20010331D0 (no)	2001-01-19	Ftalazinderivater som fosfodiesterase 4-inhibitorer
NO991994L (no)	1999-06-15	Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriksmetalloproteaseinhibitorer
EE9900182A (et)	1999-12-15	2-metoksüfenüülpiperasiini derivaadid
NO20000094D0 (no)	2000-01-07	6-Azaurcilderivater som IL-5 inhibitorer
DK0944601T3 (da)	2003-06-10	Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
PT948483E (pt)	2002-08-30	Inibidores da farnesil-transferase
NO20000860D0 (no)	2000-02-22	Syklopeptidderivater som adhesjonsinhibitorer
NO965353D0 (no)	1996-12-13	3-amino-2-okso-1-piperidineddiksyrederivater som enzyminhibitorer
ATA69896A (de)	1997-05-15	3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate